Implicit Bioscience Ltd, headquartered in Seattle, WA, is a global biotechnology company specializing in the discovery and development of innovative treatments for a range of medical conditions, including ALS, COVID-19, ophthalmic diseases, cardiovascular diseases, and neurological diseases.
The company recently made headlines with the unveiling of a groundbreaking precision nuclear medicine tool to complement their heart drug, signaling a significant advancement in their cardiology program aimed at addressing heart failure and related conditions.
Generated from the website